Burning Rock Biotech (BNR) Other Operating Expenses (2019 - 2026)

Burning Rock Biotech (BNR) has reported Other Operating Expenses for 8 consecutive years, with -$5.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses fell 5.76% year-over-year to -$5.9 million; the TTM figure through Mar 2026 stood at -$23.4 million (up 23.26% YoY), while the FY2025 annual figure was $23.6 million, down 23.72% from the prior year.
• Other Operating Expenses came in at -$5.9 million for Q1 2026 at Burning Rock Biotech, up from -$6.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was -$5.3 million in Q2 2025, with the low at -$16.0 million in Q2 2022.
• Average Other Operating Expenses over 5 years is -$8.8 million, with a median of -$7.0 million recorded in 2023.
• Across the five-year window, Other Operating Expenses slumped 67.06% in 2022 and surged 43.81% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at -$12.3 million in 2022, then jumped by 43.22% to -$7.0 million in 2023, then plunged by 59.93% to -$11.2 million in 2024, then soared by 43.81% to -$6.3 million in 2025, then advanced by 5.59% to -$5.9 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered -$5.9 million, -$6.3 million, and -$5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.